等待開盤 09-25 09:30:00 美东时间
-0.010
-0.01%
今日重点评级关注:Citizens:上调Quince Therapeutics评级至"跑赢大市",目标价77美元;康托·菲茨杰拉德:维持塞德斯医疗"超配"评级,目标价从61美元升至72美元
09-23 15:30
Citigroup analyst Benjamin Gerlinger maintains Popular (NASDAQ:BPOP) with a Buy and lowers the price target from $200 to $192.
09-22 21:22
深演智能、百度被纳入香港交易所科技100指数;中金公司拟发行不超过60亿元公司债券;江波龙单日回购超4亿元A股>>
09-09 07:58
大众金融控股(00626.HK)及要约人大众银行联合公布,于2026年8月19日,要约人要求董事会向计划股东提出建议事项,以根据公司法第99条以协议安排方式将公司私有化。
09-08 18:10
Popular (NASDAQ:BPOP) has outperformed the market over the past 5 years by 6.84% on an annualized basis producing an average annual return of 18.41%. Currently, Popular has a market capitalization of $10.93 billion. Buying $100 In BPOP: If an investor had bought $100 of BPOP stock 5 years ago, it wo...
09-08 05:15
今日重点评级关注:杰富瑞:维持拜玛林制药"买入"评级,目标价从104美元升至105美元;RBC Capital:维持Shift4 Payments"跑赢大市"评级,目标价从63美元升至67美元
09-01 08:37
Benchmark analyst Brett Rabatin maintains Popular (NASDAQ:BPOP) with a Buy and raises the price target from $214 to $216.
08-31 20:27
Popular (NASDAQ:BPOP) has outperformed the market over the past 10 years by 2.4% on an annualized basis producing an average annual return of 15.76%. Currently, Popular has a market capitalization of $10.74 billion. Buying $1000 In BPOP: If an investor had bought $1000 of BPOP stock 10 years ago, it...
08-25 04:15
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Wells Fargo analyst Terry McEvoy maintains Popular (NASDAQ:BPOP) with a Overweight and raises the price target from $180 to $200.
08-11 01:44